TD Cowen Starts NervGen Pharma Corp (NGEN) at Buy, 'A New Generation In Spinal Cord Injury Treatment Is Here'
Tweet Send to a Friend
(Updated - June 11, 2026 5:32 AM EDT)
TD Cowen analyst Joseph Thome initiates coverage on NervGen Pharma Corp ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
TD Cowen analyst Joseph Thome initiates coverage on NervGen Pharma Corp ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
